Study identifier:D2287R00120
ClinicalTrials.gov identifier:NCT03804632
EudraCT identifier:N/A
CTIS identifier:N/A
A prospective observational multi center study to assess the level of asthma control at government health clinics (Klinik Kesihatan) in Malaysia.
Asthma Control Level
N/A
No
-
All
1011
Observational
N/A
Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 May 2019 by AstraZeneca
AstraZeneca
-
A prospective observational multi center study to assess the level of asthma control at Primary Care Setting; government health clinics (Klinik Kesihatan) in Malaysia. The specific objective of the study is to assess, in real-life clinical practice in Malaysia, the level of asthma control and the potential risk factors for uncontrolled disease in asthma patients treated at government health clinics.
Despite the availability of GINA global guideline on asthma management which is widely referred by health care providers in Malaysia, the control of asthma is still a critical challenge. According to National Health and Morbidity Survey 2011, the prevalence of asthma in Malaysia is at 6.3%. Based on self-rated health status, 5.5% of patients were reported to be in good health whereas 9.9% reported poor health status although medications such as inhaled corticosteroids (ICS) and long-acting beta agonists (LABA) are widely available for effective asthma management. There is limited data to assess the level of asthma control at the Primary Care Setting in Malaysia which includes current clinical manifestation and future risk of exacerbation. Given the lack of data on Asthma control level, the awareness on the current disease control level will assist to properly characterise the patients based on GINA control level thus leading to appropriate diagnosis and treatment. The specific objective of the study is to assess, in real-life clinical practice in Malaysia, the level of GINA-defined asthma control and the potential risk factors for uncontrolled disease in asthma patients.
Location
Location
Banting, Selangor, Malaysia
Location
Rawang, Selangor, Malaysia
Location
George Town, Penang, Malaysia
Location
Seremban, Negeri Sembilan, Malaysia
Location
Port Dickson, Negeri Sembilan, Malaysia
Location
Bandar Permaisuri, Terengganu, Malaysia
Location
Kuala Terengganu, Terengganu, Malaysia
Location
Pantai Remis, Perak, Malaysia
Arms | Assigned Interventions |
---|---|
GINA-defined clinical diagnosis of Asthma All patients with GINA-defined clinical diagnosis of Asthma seen at respiratory clinic from October to December 2017 with age 18 and above | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.